PI
-
At the core of measurement — What do you want to measure? And how do you want to measure it? A COSMIN perspective
Mokkink, L. B., Herbelet, S., Terwee, C. B. & Boers, M., 1 Aug 2025, In: J. Clin. Epidemiol.. 184, 111836.Research output: Contribution to journal › Article* › Academic › peer-review
-
Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch): results of a blinded randomised test-treatment trial
Wientjes, M. H. M., Atiqi, S., Wolbink, G. J., Nurmohamed, M. T., Boers, M., Hooijberg, F., Rispens, T., de Vries, A., van Vollenhoven, R. F., Ramiro, S., van Herwaarden, N., van den Bemt, B. J. F. & den Broeder, A. A., Aug 2025, In: Annals of the rheumatic diseases. 84, 8, p. 1293-1300 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Avoiding placebo as control treatment in rheumatology trials: can we do better? Comment on the article by Kivitz et al
Boers, M., Jul 2025, In: Arthritis and Rheumatology. 77, 7, p. 949-950 2 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
- All publications